Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market.

A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...

A startup that aims to deliver a blood test to identify a biomarker linked with a specific subtype of autism—and then potentially develop early behavioral interventions and treatments—has raised $19 ...

Genetic and clinical data suggest dietary factors may influence autism risk via immune pathways, highlighting the need for ...

A test designed to identify biomarkers associated with autism just became available in most states. The test is meant to help physicians rule out autism in children who have higher likelihoods of it.